GlassScriptPhysician profile
Champalal Gupta
NPI 1962418236
$9,451.38
in general payments reported to CMS, 2019-2025
58 companies · $1,336 in 2025
The $1,336 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $723 · 2021: $1,465 · 2022: $1,492 · 2023: $1,385 · 2024: $1,706 · 2025: $1,336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,427.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,789.68 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $887.00 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $631.85 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $502.35 | 2023-2025 | Rexulti, Nuedexta |
| Neurocrine Biosciences, INC. | $482.80 | 2022-2025 | Ingrezza |
| Pfizer INC. | $455.48 | 2019-2025 | |
| Lilly USA, LLC | $359.38 | 2019-2025 | Mounjaro, Amyvid, Kisunla |
| Novartis Pharmaceuticals Corporation | $356.66 | 2019-2024 | |
| Novo Nordisk INC | $353.00 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $350.02 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $294.59 | 2019-2024 | Linzess |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.09 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $258.52 | 2019-2025 | Gattex, Trintellix |
| Aimmune Therapeutics, INC. | $221.48 | 2024-2025 | Zenpep, Vowst |
| Allergan, INC. | $204.73 | 2019-2020 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $172.24 | 2021-2023 | |
| Lundbeck LLC | $127.48 | 2019-2025 | Rexulti |
| Glaxosmithkline, LLC. | $112.13 | 2019-2025 | Shingrix, Arexvy |
| Axsome Therapeutics, INC. | $99.93 | 2024-2025 | Auvelity |
| Sunovion Pharmaceuticals INC. | $95.25 | 2019 | |
| Amarin Pharma, INC. | $91.88 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $85.51 | 2024-2025 | Fanapt |
| Exact Sciences Corporation | $79.95 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Acadia Pharmaceuticals INC | $79.72 | 2019-2020 | |
| Mylan Specialty L.P. | $77.58 | 2020-2021 | |
| Ucb, INC. | $75.24 | 2025 | Briviact |
| Gilead Sciences, INC. | $71.58 | 2019-2024 | |
| Ultragenyx Pharmaceutical INC. | $60.42 | 2021-2024 | Crysvita |
| Teva Pharmaceuticals USA, INC. | $56.17 | 2024 | Austedo Xr |
| Sanofi-Aventis U.S. LLC | $54.30 | 2024-2025 | |
| Astellas Pharma US INC | $52.59 | 2023-2024 | Veozah |
| Amphastar Pharmaceuticals, INC. | $50.69 | 2024 | Baqsimi |
| Sanofi Pasteur INC. | $47.77 | 2019 | |
| Seqirus USA INC | $44.02 | 2022-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.69 | 2022-2023 | Xifaxan |
| Ferring Pharmaceuticals INC. | $29.96 | 2023 | Rebyota |
| Indivior INC. | $29.48 | 2025 | Sublocade |
| Agile Therapeutics, INC. | $26.41 | 2021 | |
| Organogenesis INC. | $25.99 | 2024 | |
| Optinose US, INC. | $25.07 | 2024 | |
| Merck Sharp & Dohme LLC | $25.00 | 2021 | |
| Ardelyx, INC. | $24.87 | 2024 | Ibsrela |
| Avanir Pharmaceuticals, INC. | $22.89 | 2019 | |
| Vivus LLC | $22.34 | 2019 | |
| Kyowa Kirin, INC. | $21.17 | 2024 | Nourianz |
| Agios Pharmaceuticals, INC. | $20.68 | 2023 | Pyrukynd |
| Sun Pharmaceutical Industries INC. | $20.16 | 2021 | |
| Paratek Pharmaceuticals, INC. | $19.57 | 2024 | Nuzyra |
| Amgen INC. | $18.06 | 2021 | |
| Ge Healthcare | $17.24 | 2023 | |
| Qol Medical, LLC | $16.76 | 2024 | Sucraid |
| Insmed, INC. | $16.75 | 2025 | Arikayce |
| Amneal Pharmaceuticals LLC | $16.35 | 2023 | Rytary |
| Biogen, INC. | $15.96 | 2021 | |
| Daiichi Sankyo INC. | $15.55 | 2021 | |
| Abbott Laboratories | $15.53 | 2021 | |
| Scilex Pharmaceuticals INC. | $14.86 | 2019 | |
| Apria Healthcare LLC | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Champalal Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.